Medical devices, healthcare technology and the business of care
510(k) clearance · K263602

Arthrex Plates, Screws and Pins, and Washers

ARTHREX, INC. · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONK263602

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on October 29, 2026, for K263602, submitted by Arthrex, Inc. of Naples, Florida, covering Arthrex Plates, Screws and Pins, and Washers. The submission was received September 30, 2026, and falls under 21 CFR 888.3030, Single/Multiple Component Metallic Bone Fixation Appliances And Accessories, Class II, with primary product code HRS and subsequent codes HWC, HTN, MBI and JDR. The review panel and regulation medical specialty are both orthopedic.

SESE in a 510(k) pathway means the device was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record shows a special summary and states the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The specific components, materials, indications and any comparison to the predicate are not given in the available excerpts and would require the full FDA decision documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 29, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263602
Regulatory pathway
510(k) premarket notification
Applicant
ARTHREX, INC.
Product code
HRS
Decision code
SESE
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Plate, Fixation, Bone.

Applicant
Arthrex, Inc.
Product code
HRS
FDA device class
2

FDA decision timeline

  1. K263602 received

    Application receipt date recorded by FDA.

  2. K263602 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HRS

Product / regulatory recordCompanyPathwayDecision dateSource
Hero Orthopedics, LLC510(k) clearanceNov 2, 2026FDA
Skeletal Dynamics, Inc.510(k) clearanceOct 26, 2026FDA
GLOBUS MEDICAL, INC.510(k) clearanceOct 23, 2026FDA
Pace Surgical510(k) clearanceOct 23, 2026FDA
Tdm Co., Ltd.510(k) clearanceOct 15, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Arthrex, Inc.

Headquarters
Not reported
Brand website
arthrex.com
FDA applicant address
Naples, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records